THYROID CANCER, PAPILLARY
Clinical trials for THYROID CANCER, PAPILLARY explained in plain language.
Never miss a new study
Get alerted when new THYROID CANCER, PAPILLARY trials appear
Sign up with your email to follow new studies for THYROID CANCER, PAPILLARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Drug cocktail aims to Re-Sensitize resistant thyroid tumors to radioiodine
Disease control CompletedThis early-phase trial tested two drugs, vemurafenib and copanlisib, in 8 people with advanced thyroid cancer that had stopped responding to radioiodine therapy. The goal was to see if the combination could make tumors sensitive to radioiodine again and shrink them. The study als…
Matched conditions: THYROID CANCER, PAPILLARY
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:50 UTC
-
Hidden cancer cells force second surgery in thyroid patients
Knowledge-focused CompletedThis study looked at 314 adults with small, early-stage papillary thyroid cancer who were scheduled for a less extensive surgery (lobectomy). Doctors checked lymph nodes during the operation and found that many patients had hidden cancer spread, requiring a second surgery to remo…
Matched conditions: THYROID CANCER, PAPILLARY
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC